Literature DB >> 19398291

Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients.

Daisuke Takenaka1, Yoshiharu Ohno, Hisanobu Koyama, Munenobu Nogami, Yumiko Onishi, Keiko Matsumoto, Sumiaki Matsumoto, Takeshi Yoshikawa, Kazuro Sugimura.   

Abstract

PURPOSE: The purpose of this study was to prospectively and directly compare diagnostic capabilities of whole-body integrated FDG-PET/CT and standard radiologic examination for assessment of recurrence in postoperative non-small cell lung cancer (NSCLC) patients.
MATERIALS AND METHODS: A total of 92 consecutive pathologically diagnosed NSCLC patients (65 males, 27 females; mean age, 71 years) underwent pathologically and surgically proven complete resection, followed by prospective whole-body FDG-PET/CT and standard radiological examinations. Final diagnosis of recurrence was based on the results of more than 1 year of follow-up and/or pathological examinations. On both methods, the probability of recurrence was assessed in each patient by using a five-point visual scoring system, and the each final diagnosis was made by consensus between two readers. Kappa analyses were performed to determine inter-observer agreement for both methods, and ROC analyses were used to compare capability of the two methods for assessment of postoperative recurrence on a per-patient basis. Sensitivity, specificity and accuracy were also compared between PET/CT and standard radiological examination by means of McNemar's test.
RESULTS: All inter-observer agreements were almost perfect (integrated PET/CT: kappa=0.89; standard radiological examination: kappa=0.81). There were no statistically significant differences in area under the curve, sensitivity, specificity and accuracy between integrated FDG-PET/CT and standard radiologic examinations (p>0.05).
CONCLUSION: Integrated FDG-PET/CT can be used for assessment of postoperative recurrence in NSCLC patients with accuracy as good as that of standard radiological examinations. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398291     DOI: 10.1016/j.ejrad.2009.03.007

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  13 in total

1.  Current status of postoperative follow-up for lung cancer in Japan: questionnaire survey by the Setouchi Lung Cancer Study Group-A0901.

Authors:  Shigeki Sawada; Hiroshi Suehisa; Motohiro Yamashita; Masao Nakata; Norihito Okumura; Kazunori Okabe; Hiroshige Nakamura; Hirohito Tada; Shinichi Toyooka; Hiroshi Date
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-02-12

2.  PET/CT vs. non-contrast CT alone for surveillance 1-year post lobectomy for stage I non-small-cell lung cancer.

Authors:  Bari Dane; Vadim Grechushkin; April Plank; William Moore; Thomas Bilfinger
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-09-19

Review 3.  [PET/CT for diagnostics and therapy stratification of lung cancer].

Authors:  C Kratochwil; U Haberkorn; F L Giesel
Journal:  Radiologe       Date:  2010-08       Impact factor: 0.635

Review 4.  Post-therapeutic positron emission tomography/computed tomography for early detection of non-small cell lung cancer recurrence.

Authors:  Sonja Sudarski; Thomas Henzler; Stefan O Schoenberg
Journal:  Transl Lung Cancer Res       Date:  2013-08

5.  Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.

Authors:  Jay P Reddy; Chad Tang; Tina Shih; Bumyang Kim; Charissa Kim; Quynh-Nhu Nguyen; James Welsh; Marcelo Benveniste; Jianjun Zhang; Zhongxing Liao; Daniel R Gomez
Journal:  Clin Lung Cancer       Date:  2016-11-10       Impact factor: 4.785

6.  Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.

Authors:  Christopher T Erb; Kevin W Su; Pamela R Soulos; Lynn T Tanoue; Cary P Gross
Journal:  Lung Cancer       Date:  2016-07-19       Impact factor: 5.705

7.  18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.

Authors:  Hiroaki Toba; Shoji Sakiyama; Hideki Otsuka; Yukikiyo Kawakami; Hiromitsu Takizawa; Koichiro Kenzaki; Kazuya Kondo; Akira Tangoku
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-08-21

8.  A Comparison of microCT and microPET for Evaluating Lymph Node Metastasis in a Rat Model.

Authors:  Paul Flechsig; Clemens Kratochwil; Arne Warth; Daniel Rath; Viktoria Eichwald; Peter E Huber; Hans-Ulrich Kauczor; Uwe Haberkorn; Frederik L Giesel
Journal:  Mol Imaging Biol       Date:  2016-04       Impact factor: 3.488

9.  FDG uptake at the bronchial stump after curative lobectomy for non-small cell lung cancer.

Authors:  Caroline Keyzer; Florence Corbusier; Eirini Kyratzi; Youri Sokolow; Pierre Alain Gevenois; Serge Goldman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-28       Impact factor: 9.236

Review 10.  Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.

Authors:  Andrea Caulo; Saeed Mirsadraee; Fabio Maggi; Lucia Leccisotti; Edwin J R van Beek; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2011-10-04       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.